NCT00124683View on ClinicalTrials.gov

Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1

PHASE2CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

September 30, 2001

Study Completion Date

May 31, 2007

Conditions
Tobacco Use CessationTobacco Use DisorderSchizophrenia
Interventions
DRUG

Bupropion

DRUG

nicotine transdermal patch

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00124683 - Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1 | Biotech Hunter | Biotech Hunter